Sutro Biopharma Inc. (STRO) Prices 11M Share Common Offering at $7.75/Sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. TGT
2. WMT
3. SPY
4. ROST
5. EL
6. ADI
7. LOW
8. MRK
9. BILL
10. NTES

Go back to Sutro Biopharma Inc. (STRO) Prices 11M Share Common Offering at $7.75/Sh

After-Hours Stock Movers 05/11: (CBAY) (YRCW) (NVAX) Higher; (GNFT) (STRO) (EB) Lower (more...)

May 11, 2020 5:53 PM EDT

Today's After-Hours Stock Movers:

CymaBay Therapeutics (CBAY) 119% HIGHER; independent expert panel unanimously concludes there is no clinical, biochemical or histological evidence of seladelpar-induced liver injury in Phase 2b NASH study.

GENFIT (Nasdaq: GNFT) 50.7% LOWER; announced results from an interim analysis of the RESOLVE-IT Phase 3 trial evaluating once-daily, 120mg of elafibranor in adults with non-alcoholic steatohepatitis (NASH). The trial did not meet the predefined primary endpoint of NASH resolution without worsening of fibrosis in the ITT population of 1,070 patients. The response rate in... More

Sutro Biopharma Inc. (STRO) Announces Proposed Public Offering of Common Stock

May 11, 2020 4:32 PM EDT

Sutro Biopharma, Inc. (Nasdaq: STRO), a clinical stage drug discovery, development and manufacturing company focused on deploying its proprietary integrated cell-free protein synthesis platform, XpressCF®, to create a broad variety of optimally designed, next-generation protein therapeutics initially for cancer and autoimmune disorders, today announced a proposed underwritten public... More